Martin Investment Management, LLC Gilead Sciences, Inc. Transaction History

Martin Investment Management, LLC

$407 Million
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $4.26 Million - $5.33 Million	-73,472 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $798,153 - $905,919	-12,302 Reduced 14.34%	73,472 $5.34 Million
Q3 2021 Nov 01, 2021	SELL	$67.69 - $73.03 $80,077 - $86,394	-1,183 Reduced 1.36%	85,774 $5.99 Million
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $63,216 - $69,072	-996 Reduced 1.13%	86,957 $5.99 Million
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $623,340 - $711,230	10,389 Added 13.39%	87,953 $5.68 Million

Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $87,920 - $100,181	-1,552 Reduced 1.96%	77,564 $4.52 Million
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $204,619 - $257,273	3,295 Added 4.35%	79,116 $5 Million
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $20,110 - $23,352	-278 Reduced 0.37%	75,821 $5.83 Million
Q1 2020 Apr 14, 2020	SELL	$62.63 - $80.22 $1.22 Million - $1.56 Million	-19,485 Reduced 20.39%	76,099 $5.69 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $3.4 Million - $3.74 Million	-55,186 Reduced 36.6%	95,584 $6.21 Million
Q3 2019 Nov 04, 2019	BUY	$62.51 - $69.0 $974,280 - $1.08 Million	15,586 Added 11.53%	150,770 $9.56 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $111,613 - $125,161	-1,804 Reduced 1.32%	135,184 $9.13 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $2,000 - $2,241	32 Added 0.02%	136,988 $8.91 Million
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $133,188 - $173,800	-2,200 Reduced 1.58%	136,956 $8.57 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $1.91 Million - $2.12 Million	-26,842 Reduced 16.17%	139,156 $10.7 Million
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $317,717 - $370,604	4,897 Added 3.04%	165,998 $11.8 Million
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $1.06 Million - $1.29 Million	14,540 Added 9.92%	161,101 $12.1 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $10.6 Million - $12.5 Million	146,561	146,561 $11.9 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.28 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.75 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.71 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.14 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.9 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Martin Investment Management, LLC with notifications on news.

Account